Immunic
IMUX
52 hedge funds and large institutions have $88.1M invested in Immunic in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 7 closing their positions.
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
112% more call options, than puts
Call options by funds: $2.12M | Put options by funds: $1M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 54 → 52 (-2)
24% less capital invested
Capital invested by funds: $115M → $88.1M (-$27.2M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$1.47M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$486K |
| 3 |
Goldman Sachs
New York
|
+$427K |
| 4 |
State Street
Boston,
Massachusetts
|
+$417K |
| 5 |
PA
Perceptive Advisors
New York
|
+$261K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.7M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$771K |
| 3 |
DC
Deere & Company
Moline,
Illinois
|
-$655K |
| 4 |
Morgan Stanley
New York
|
-$386K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$246K |
IMUX Hedge Fund Activity: Q1 2016 in Review
52 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2016, worth a combined $88.1M — down 24% from $115M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of IMUX and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 23 added.
The largest buyer was RS Investment Management, adding an estimated $1.47M. The largest seller was Fidelity Investments, cutting an estimated $4.7M.
- 52 institutional investors held Immunic (IMUX) as of Q1 2016, down from 54 in Q4 2015.
- Funds reported $88.1M of Immunic stock for Q1 2016, down 24% quarter-over-quarter.
- 5 funds opened new Immunic positions in Q1 2016 and 7 closed out, a net change of -2 holders.
- The largest Immunic buyer in Q1 2016 was RS Investment Management, an estimated $1.47M added.
- The largest Immunic seller in Q1 2016 was Fidelity Investments, an estimated $4.7M sold.
Based on aggregated 13F filings for Q1 2016.